MOUNJARO vs ZEPBOUND

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Attribute	MOUNJARO	ZEPBOUND
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TIRZEPATIDE	TIRZEPATIDE
Manufacturer	Eli Lilly and Co	Eli Lilly and Co
Dosage forms	Injectable	Injectable
Drug class	Glp-1 Receptor Agonist	Glp-1 Receptor Agonist
Boxed warning	Boxed warning	Boxed warning
Half-life	about 5 days (roughly 120 hours)	about 5 days (roughly 120 hours)
Treats	Type 2 Diabetes Mellitus	Type 2 Diabetes Mellitus

mounjaro zepbound

Rating

New

Pharmacy pays

—

Type

Active ingredient

TIRZEPATIDE

Manufacturer

Eli Lilly and Co

Dosage forms

Injectable

Drug class

Glp-1 Receptor Agonist

Boxed warning

Half-life

about 5 days (roughly 120 hours)

Treats

Type 2 Diabetes Mellitus

Frequently asked questions

What is the difference between Mounjaro and Zepbound?

Both Mounjaro and Zepbound share the active ingredient Tirzepatide.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.